News

The investment giant behind WeWork isn’t afraid to make big, questionable-seeming bets. At the very least, though, SoftBank ...
Neither Y2K bust nor WeWork's failure deter SoftBank's mercurial chief Masayoshi Son to venture again into speculative territory. This time he's joining forces with a boutique bank-backed blank-check ...
Fundraising is picking up among crypto venture funds after two dismal years, as investors hope to profit from the friendly ...
Cantor Fitzgerald is maintaining a bearish stance on equities, cautioning that the recent market rebound which has been driven largely by investor positioning—is likely behind us. The firm ...
Cantor Fitzgerald, SoftBank Group, Tether, and Bitfinex have joined hands to launch Twenty One. The consortium of traditional finance (TradFi) and decentralized finance (DeFi) firms announced on ...
Brandon Lutnick, chair of investment banking firm Cantor Fitzgerald, is reportedly partnering with SoftBank, Tether and Bitfinex to create a $3 billion crypto acquisition company. Lutnick and the ...
UBS Group is in talks to sell its hedge fund unit O’Connor to Cantor Fitzgerald, according to people familiar with the matter. The deal could involve a possible revenue sharing agreement ...
Cantor Fitzgerald is set to launch a $3 billion Bitcoin investment initiative in collaboration with SoftBank, Tether, and Bitfinex, according to a report by the Financial Times. The project ...
On Wednesday, Cantor Fitzgerald reiterated an Overweight rating on shares of Summit Therapeutics plc (NASDAQ:SMMT), following the company’s recent clinical trial updates. The company ...
Cantor Fitzgerald analyst Steve Seedhouse assumed coverage of ProQR Therapeutics (PRQR) with an Overweight rating and $8 price target ProQR is a leader in RNA editing and the initial biomarker ...